Abstract
This Special Issue of Pharmaceuticals presents one review and six original articles that are demonstrative of the importance of glycomimetics and glycoconjugates as privileged groups of carbohydrate-based molecules in the search for and development of bioactive substances for therapeutic/pharmaceutical purposes. Carbohydrates and glycoconjugates play important roles in biological events that are relevant for life and the progress of various diseases. The study of their structures and functions is important for developing therapeutic approaches targeting the disease-associated enzymes and events in which these molecules are implicated.
